Patents by Inventor Tai Wai Chin

Tai Wai Chin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression
    Patent number: 5661126
    Abstract: This application concerns the treatment of certain tumors using an effective amount of the glycoprotein Mullerian Inhibiting Substance (MIS). This application further concerns the treatment of certain tumors using an effective amount of the C-terminal fragment of MIS. Also, this application concerns DNA sequences encoding the C-terminal fragment of MIS, vectors containing the DNA sequence and transformed host cells capable of producing the C-terminal fragment. This application further concerns treating certain tumors by transfecting tumor cells with a gene coding for MIS or the C-terminal fragment of MIS. Gene therapy treatments for inhibiting growth of certain tumors are also provided. Further, this application concerns a method for modulating class I histocompatibility antigens with MIS and EGF.
    Type: Grant
    Filed: July 7, 1994
    Date of Patent: August 26, 1997
    Assignee: The General Hospital Corporation
    Inventors: Patricia K. Donahoe, Tai Wai Chin, Robert L. Parry, James Epstein, Richard C. Ragin, David T. MacLaughlin, Edward M. Barksdale